Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-07 Purchase |
2024-03-11 4:43 pm |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff CHIEF COMMERCIAL OFFICER |
62,484 | $0.42 | $26,243 | 808,459 (Direct) |
View |
| 2023-01-20 Sale |
2023-01-24 8:08 pm |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer |
267,000 | $1.11 | $296,370 | 745,975 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 8:05 pm |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer |
164,155 | $1.2411 | $203,726 | 1,012,975 (Direct) |
View |
| 2021-12-03 Purchase |
2021-12-06 5:25 pm |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer |
35,200 | $1.34 | $47,168 | 1,177,130 (Direct) |
View |
| 2021-02-23 Sale |
2021-02-25 8:52 pm |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer |
8,554 | $2.088 | $17,861 | 1,141,930 (Direct) |
View |
| 2021-02-12 Sale |
2021-02-17 9:14 pm |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer |
56,973 | $2.55 | $145,281 | 1,150,484 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-20 Option Award |
2024-03-22 5:00 pm |
N/A 2034-03-20 |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff CHIEF COMMERCIAL OFFICER |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-04-17 Option Award |
2023-04-19 5:41 pm |
N/A 2033-04-17 |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer |
192,143 | $0 | 192,143 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 6:47 pm |
N/A 2031-12-21 |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-12-21 Option Award |
2021-12-23 5:32 pm |
N/A 2031-12-21 |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer |
800,000 | $0 | 800,000 (Direct) |
View |